Kirk AD - Search Results

1

Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation.

Turgeon NA, Avila JG, Cano JA, Hutchinson JJ, Badell IR, Page AJ, Adams AB, Sears MH, Bowen PH, Kirk AD, Pearson TC, Larsen CP. Turgeon NA, et al. Among authors: kirk ad. Am J Transplant. 2010 Sep;10(9):2082-91. doi: 10.1111/j.1600-6143.2010.03212.x. Am J Transplant. 2010. PMID: 20883542 Free PMC article. Clinical Trial.

2

Effect of donor factors on early graft survival in adult cadaveric renal transplantation.

Swanson SJ, Hypolite IO, Agodoa LY, Batty DS Jr, Hshieh PB, Cruess D, Kirk AD, Peters TG, Abbott KC. Swanson SJ, et al. Among authors: kirk ad. Am J Transplant. 2002 Jan;2(1):68-75. doi: 10.1034/j.1600-6143.2002.020112.x. Am J Transplant. 2002. PMID: 12095059 Free article.

3

Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model.

Montgomery SP, Mog SR, Xu H, Tadaki DK, Hirshberg B, Berning JD, Leconte J, Harlan DM, Hale D, Kirk AD. Montgomery SP, et al. Among authors: kirk ad. Am J Transplant. 2002 Apr;2(4):381-5. doi: 10.1034/j.1600-6143.2002.20415.x. Am J Transplant. 2002. PMID: 12118862 Free article.

4

IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.

Preston EH, Xu H, Dhanireddy KK, Pearl JP, Leopardi FV, Starost MF, Hale DA, Kirk AD. Preston EH, et al. Among authors: kirk ad. Am J Transplant. 2005 May;5(5):1032-41. doi: 10.1111/j.1600-6143.2005.00796.x. Am J Transplant. 2005. PMID: 15816883 Free article.

5

Transplant tolerance: converging on a moving target.

Newell KA, Larsen CP, Kirk AD. Newell KA, et al. Among authors: kirk ad. Transplantation. 2006 Jan 15;81(1):1-6. doi: 10.1097/01.tp.0000179149.12979.13. Transplantation. 2006. PMID: 16421467 Review.

6

A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression.

Larsen CP, Knechtle SJ, Adams A, Pearson T, Kirk AD. Larsen CP, et al. Among authors: kirk ad. Am J Transplant. 2006 May;6(5 Pt 1):876-83. doi: 10.1111/j.1600-6143.2006.01259.x. Am J Transplant. 2006. PMID: 16611323 Free article. Review.

7

Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab.

Kirk AD, Cherikh WS, Ring M, Burke G, Kaufman D, Knechtle SJ, Potdar S, Shapiro R, Dharnidharka VR, Kauffman HM. Kirk AD, et al. Am J Transplant. 2007 Nov;7(11):2619-25. doi: 10.1111/j.1600-6143.2007.01972.x. Epub 2007 Sep 14. Am J Transplant. 2007. PMID: 17868060 Free PMC article.

8

Alemtuzumab.

Weaver TA, Kirk AD. Weaver TA, et al. Among authors: kirk ad. Transplantation. 2007 Dec 27;84(12):1545-7. doi: 10.1097/01.tp.0000296680.75175.67. Transplantation. 2007. PMID: 18165760

9

Monocyte infiltration and kidney allograft dysfunction during acute rejection.

Girlanda R, Kleiner DE, Duan Z, Ford EA, Wright EC, Mannon RB, Kirk AD. Girlanda R, et al. Among authors: kirk ad. Am J Transplant. 2008 Mar;8(3):600-7. doi: 10.1111/j.1600-6143.2007.02109.x. Am J Transplant. 2008. PMID: 18294156 Free PMC article.

10

The Banff 2007 working classification of skin-containing composite tissue allograft pathology.

Cendales LC, Kanitakis J, Schneeberger S, Burns C, Ruiz P, Landin L, Remmelink M, Hewitt CW, Landgren T, Lyons B, Drachenberg CB, Solez K, Kirk AD, Kleiner DE, Racusen L. Cendales LC, et al. Among authors: kirk ad. Am J Transplant. 2008 Jul;8(7):1396-400. doi: 10.1111/j.1600-6143.2008.02243.x. Am J Transplant. 2008. PMID: 18444912 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

329 results

Search Page